PRMT5 Inhibitor BMS-986504: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Condition	Trials
Colorectal cancer	1
Metastatic Biliary Tract Carcinoma	1
Metastatic Colon Carcinoma	1
Metastatic Esophageal Carcinoma	1
Metastatic Malignant Digestive System Neoplasm	1
Metastatic Malignant Solid Neoplasm	1
Metastatic Pancreatic Carcinoma	1
Pancreatic cancer	1
Stage IV Colon Cancer AJCC v8	1
Stage IV Pancreatic Cancer AJCC v8	1

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
NCT07594626 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

1 recruiting trial across 10 conditions.

No. For the full record, search ClinicalTrials.gov.